Legare Meglio cowboy chinese clinical oncology impact factor arco esso partire
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 - Clarivate
Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Chinese Journal of Clinical Oncology
Frontiers | In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China | Oncology
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study - The Lancet
The dawn of China biopharma innovation | McKinsey
Peer-reviewed Oncology & Cancer Research Journal | Oncotarget
Home - Chinese Journal of Cancer Research
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
The dawn of China biopharma innovation | McKinsey
Cancer drug development in China: recent advances and future challenges - ScienceDirect
Journal of Clinical Oncology - Impact Factor, Overall Ranking, Rating, h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR), Abbreviation, other Important Details | Resurchify
China at the threshold | Nature Biotechnology
Home - Chinese Clinical Oncology
Chinese Society of Clinical Oncology|CSCO
Home - Chinese Clinical Oncology
About Annals of Oncology Impact factor: 32.976
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing | Nature Communications
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Chinese Medicine in Cancer Treatment – How is it Practised in the East and the West? - Clinical Oncology
Chinese Society of Clinical Oncology|CSCO
Chinese Clinical Oncology
State of Cancer Research Around the Globe
Cancer drug development in China: recent advances and future challenges - ScienceDirect